FACTOR IX GRIFOLS /ML
INSTITUTO GRIFOLS S A
Identification
- Active ingredient (INN)
- FACTEUR DE COAGULATION IX
- Internal code
- 12 J 170
- Country of Origin
- Spain
- Pharmaceutical form
- Powder for Injectable Sol.
- Prescription List
- Highly Regulated (List I)
- Packaging
- flc de 500ui/1sering pre rempli de 10ml solv et 1 flc de 1000ui/sering pre rempli de 20 ml
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Associated Conditions
Lactation Diabetes Female likely to be pregnant Pregnancy Hepatitis Male of childbearing age Hepatic impairment Renal impairment Important tumour mass Newborn exposed in utero to the medicine Obesity Digestive pathology Elderly Subject at risk of hepatopathies Subject under 18 Proliferative tumour.
Mechanism of Action
The laboratory is a complex of the cells of the cell.
Preclinical data suggest that the biological activity of the vedotin brentuximab is the result of a multistage process.
The binding of the
CD30 antigen to the cell surface triggers the internalization of the CD30 complex which is then transferred to the cell compartment.
Within the cell, the active substance of the tumour cells is the CD30-representative CD-representative CD-representative CD-representative CD-representative DNA-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive-reactive.
Adverse Effects
- Neutropenia (Very common)
- ALT (increase) (Common)
- ASAT (increase) (Common)
- Hyperglycaemia (Common)
- Tumor lysis syndrome (Uncommon)
- Alopecia (Common)
- Lyell's syndrome (Uncommon)
- Pruritus (Very common)
- Rash (Very common)
- Stevens-Johnson Syndrome (Uncommon)
- Frisher (Common)
- Fever (Very common)
- Fatigue (Very common)
- Anemia (Common)
- Febrile neutropenia (Uncommon)
- Thrombocytopenia (Common)
- Anaphylactic reaction (Uncommon)
- DRESS syndrome Staphylococcal bacteria (Uncommon)
- Bacteriaemia Pneumonia in Pneumocystis jirovecii (Uncommon)
- Oral candidiasis (Common)
- Reactivation of cytomegalovirus infection (Uncommon)
- Zona (Common)
- Cytomegalovirus infection (Uncommon)
- Herpes (Common)
- Infection (Very common)
- Sepsis (Uncommon)
- Opportunistic infection
- Infusion-related reaction (Very common)
- Extravasation at the injection site Anorexia (Very common)
- Weight (decrease) (Very common)
- Feeling dizzy (Common)
- Stomatitis (Very common)
- Insomnia (Very common)
- Septic shock (Common)
- Constipation (Very common)
- Acute Pancreatitis (Uncommon)
- Nausea (Very common)
- Diarrhoea (Very common)
- Abdominal pain (Very common)
- Vomiting (Very common)
- Sleeping (Common)
- Bone pain (Very common)
- Muscle pain (Very common)
- Joint pain (Very common)
- Peripheral sensory neuropathy (Very common)
- Demyelinating polyneuropathy (Uncommon)
- Peripheral motor neuropathy (Very common)
- Progressive multifocal leukoencephalopathy Headache Neuropathy Peripheral neuropathy
- Cough (Very common)
- Dyspnoea (Very common)
- Pneumonia (Common)
- Upper respiratory tract infection (Very common).